Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-737,168
Closed -$58K 134
2015
Q1
$58K Buy
737,168
+99,498
+16% +$3.16M 0.04% 139
2014
Q4
$62K Buy
637,670
+585,602
+1,125% +$16.8M 0.02% 215
2014
Q3
$17K Buy
+52,068
New +$1.46M 0.01% 161
2014
Q1
Sell
-4,232,337
Closed -$223K 295
2013
Q4
$223K Buy
4,232,337
+847,205
+25% +$24.7M 0.01% 180
2013
Q3
$1.27M Buy
3,385,132
+3,194,569
+1,676% +$86.9M 0.19% 114
2013
Q2
$116K Buy
+190,563
New +$5.27M 0.01% 210

Other funds holding PFE

Saiers Capital's PFE Position: Q2 2015 in Review

Saiers Capital sold out of Pfizer (PFE) in Q2 2015, closing a stake of 31,444 shares — an estimated $1.04M sold.

Saiers Capital first reported a position in PFE in Q2 2013 and held it in 6 quarters. The position peaked at $15.7M in Q3 2013. 1,886 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

  • Saiers Capital reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
  • Saiers Capital sold 31,444 Pfizer shares in Q2 2015, an estimated $1.04M.
  • Saiers Capital first reported a position in Pfizer in Q2 2013 and held it in 6 quarters.
  • Saiers Capital's Pfizer position peaked at $15.7M in Q3 2013.
  • 1,886 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Saiers Capital's 13F filing for Q2 2015, filed 11 Aug 2015.